Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
04 2021
Historique:
received: 17 08 2020
accepted: 31 10 2020
pubmed: 18 11 2020
medline: 17 4 2021
entrez: 17 11 2020
Statut: ppublish

Résumé

Despite patients' widespread use and acceptance of complementary and integrative medicine (IM), few data are available regarding health-care professionals' current implementation of it in clinical routine. A national survey was conducted to assess gynecologists' attitudes to and implementation of complementary and integrative treatment approaches. The Working Group on Integrative Medicine of the German Society of Gynecological Oncology conducted an online survey in collaboration with the German Society of Gynecology and Obstetrics (DGGG) in July 2019. A 29-item survey was sent to all DGGG members by email. Questionnaires from 180 gynecologists were analyzed, of whom 61 were working office-based in private practice and 95 were employed in hospitals. Seventy percent stated that IM concepts are implemented in their routine clinical work. Most physicians reported using IM methods in gynecological oncology. The main indications for IM therapies were fatigue (n = 98), nausea and vomiting (n = 89), climacteric symptoms (n = 87), and sleep disturbances (n = 86). The most commonly recommended methods were exercise therapy (n = 86), mistletoe therapy (n = 78), and phytotherapy (n = 74). Gynecologists offering IM were more often female (P = 0.001), more often had qualifications in anthroposophic medicine (P = 0.005) or naturopathy (P = 0.019), and were more often based in large cities (P = 0.016). There is strong interest in IM among gynecologists. The availability of evidence-based training in IM is increasing. Integrative therapy approaches are being implemented in clinical routine more and more, and integrative counseling services are present all over Germany. Efforts should focus on extending evidence-based knowledge of IM in both gynecology and gynecological oncology.

Identifiants

pubmed: 33201377
doi: 10.1007/s00404-020-05869-9
pii: 10.1007/s00404-020-05869-9
pmc: PMC7985114
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

967-980

Références

Kalder M, Muller T, Fischer D, Muller A, Bader W, Beckmann MW, Brucker C, Hack CC, Hanf V, Hasenburg A, Hein A, Jud S, Kiechle M, Klein E, Paepke D, Rotmann A, Schutz F, Dobos G, Voiss P, Kummel S (2016) A review of integrative medicine in gynaecological oncology. Geburtshilfe Frauenheilkd 76(2):150–155. https://doi.org/10.1055/s-0042-100208
doi: 10.1055/s-0042-100208 pubmed: 26941447 pmcid: 4771505
Xue CC, Zhang AL, Lin V, Da Costa C, Story DF (2007) Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med 13(6):643–650. https://doi.org/10.1089/acm.2006.6355
doi: 10.1089/acm.2006.6355 pubmed: 17718647
Su D, Li L (2011) Trends in the use of complementary and alternative medicine in the United States: 2002–2007. J Health Care Poor Underserved 22(1):296–310. https://doi.org/10.1353/hpu.2011.0002
doi: 10.1353/hpu.2011.0002 pubmed: 21317523
Hunt KJ, Coelho HF, Wider B, Perry R, Hung SK, Terry R, Ernst E (2010) Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract 64(11):1496–1502. https://doi.org/10.1111/j.1742-1241.2010.02484.x
doi: 10.1111/j.1742-1241.2010.02484.x pubmed: 20698902
Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH (2018) Use of complementary and alternative medicine in Europe: health-related and sociodemographic determinants. Scandinavian J Public Health 46(4):448–455. https://doi.org/10.1177/1403494817733869
doi: 10.1177/1403494817733869
Horneber M, Fischer I, Dimeo F, Ruffer JU, Weis J (2012) Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Deutsches Arzteblatt Int 109(9):161–171. https://doi.org/10.3238/arztebl.2012.0161 ((quiz 172))
doi: 10.3238/arztebl.2012.0161
Kessel KA, Klein E, Hack CC, Combs SE (2018) Complementary medicine in radiation oncology : German health care professionals’ current qualifications and therapeutic methods. Strahlenther Onkol 194(10):904–910. https://doi.org/10.1007/s00066-018-1345-8
doi: 10.1007/s00066-018-1345-8 pubmed: 30073483
Baum M, Ernst E, Lejeune S (2004) Horneber M (2006) Role of complementary and alternative medicine in the care of patients with breast cancer: report of the European Society of Mastology (EUSOMA) Workshop, Florence, Italy. Eur J Cancer 42(12):1702–1710. https://doi.org/10.1016/j.ejca.2006.02.020
doi: 10.1016/j.ejca.2006.02.020
Hack CC, Huttner NB, Fasching PA, Beckmann MW (2015) Development and validation of a standardized questionnaire and standardized diary for use in integrative medicine consultations in gynecologic oncology. Geburtshilfe Frauenheilkd 75(4):377–383. https://doi.org/10.1055/s-0035-1545850
doi: 10.1055/s-0035-1545850 pubmed: 26028695 pmcid: 4437756
Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P, Kucuk O, Mailman J, Mao JJ (2017) A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr. https://doi.org/10.1093/jncimonographs/lgx012
doi: 10.1093/jncimonographs/lgx012 pubmed: 29140494 pmcid: 6061411
National Center for Complementary and Integrative Health Complementary, alternative, or integrative health: What’s in a name? https://nccih.nih.gov/health/integrative-health-integrative . Accessed 23 Jul 2019
Leis AM, Weeks LC, Verhoef MJ (2008) Principles to guide integrative oncology and the development of an evidence base. Curr Oncol 15(Suppl 2):s83-87. https://doi.org/10.3747/co.v15i0.278
doi: 10.3747/co.v15i0.278 pubmed: 18769572 pmcid: 2528554
Seely DM, Weeks LC, Young S (2012) A systematic review of integrative oncology programs. Curr Oncol 19(6):e436-461. https://doi.org/10.3747/co.19.1182
doi: 10.3747/co.19.1182 pubmed: 23300368 pmcid: 3503675
Explore IM Integrative Medicine (2011) East Meets West: How integrative medicine is changing Health Care. https://exploreim.ucla.edu/health-care/east-meets-west-how-integrative-medicine-is-changing-health-care/ . 14 July 2020
Munstedt K, Entezami A, Wartenberg A, Kullmer U (2000) The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT). Eur J Cancer 36(16):2090–2095. https://doi.org/10.1016/s0959-8049(00)00194-5
doi: 10.1016/s0959-8049(00)00194-5 pubmed: 11044646
National Center for Complementary and Integrative Health (2019) Naturopathy. https://www.nccih.nih.gov/health/naturopathy . Accessed 14 Oct 2020
Michalsen A (2019) The nature cure: a doctor’s guide to the science of natural medicine. Viking, New York
Kienle GS, Ben-Arye E, Berger B, Cuadrado Nahum C, Falkenberg T, Kapocs G, Kiene H, Martin D, Wolf U, Szoke H (2019) Contributing to global health: development of a consensus-based whole systems research strategy for anthroposophic medicine. Evid Based Complement Alternat Med. https://doi.org/10.1155/2019/3706143
doi: 10.1155/2019/3706143 pubmed: 31781267 pmcid: 6875260
Klein E, Beckmann MW, Bader W, Brucker C, Dobos G, Fischer D, Hanf V, Hasenburg A, Jud SM, Kalder M, Kiechle M, Kummel S, Muller A, Muller MT, Paepke D, Rotmann AR, Schutz F, Scharl A, Voiss P, Wallwiener M, Witt C, Hack CC (2017) Gynecologic oncologists’ attitudes and practices relating to integrative medicine: results of a nationwide AGO survey. Arch Gynecol Obstet 296(2):295–301. https://doi.org/10.1007/s00404-017-4420-y
doi: 10.1007/s00404-017-4420-y pubmed: 28597400 pmcid: 5509774
Paul M, Davey B, Senf B, Stoll C, Munstedt K, Mucke R, Micke O, Prott FJ, Buentzel J, Hubner J (2013) Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol 139(9):1515–1522. https://doi.org/10.1007/s00432-013-1460-y
doi: 10.1007/s00432-013-1460-y pubmed: 23832609
Tautz E, Momm F, Hasenburg A, Guethlin C (2012) Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. Eur J Cancer 48(17):3133–3139. https://doi.org/10.1016/j.ejca.2012.04.021
doi: 10.1016/j.ejca.2012.04.021 pubmed: 22633625
Fasching PA, Thiel F, Nicolaisen-Murmann K, Rauh C, Engel J, Lux MP, Beckmann MW, Bani MR (2007) Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer 15(11):1277–1284. https://doi.org/10.1007/s00520-007-0231-1
doi: 10.1007/s00520-007-0231-1 pubmed: 17333294
Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS (2006) Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J 12(6):467–474. https://doi.org/10.1097/00130404-200611000-00006
doi: 10.1097/00130404-200611000-00006 pubmed: 17207316
Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Eng J Med 340(22):1733–1739. https://doi.org/10.1056/NEJM199906033402206
doi: 10.1056/NEJM199906033402206
Munstedt K, Maisch M, Tinneberg HR, Hubner J (2014) Complementary and alternative medicine (CAM) in obstetrics and gynaecology: a survey of office-based obstetricians and gynaecologists regarding attitudes towards CAM, its provision and cooperation with other CAM providers in the state of Hesse, Germany. Arch Gynecol Obstet 290(6):1133–1139. https://doi.org/10.1007/s00404-014-3315-4
doi: 10.1007/s00404-014-3315-4 pubmed: 24973867
Furlow ML, Patel DA, Sen A, Liu JR (2008) Physician and patient attitudes towards complementary and alternative medicine in obstetrics and gynecology. BMC Complement Altern Med 8:35. https://doi.org/10.1186/1472-6882-8-35
doi: 10.1186/1472-6882-8-35 pubmed: 18582380 pmcid: 2464574
Hack CC, Wasner S, Meyer J, Haberle L, Jud S, Hein A, Wunderle M, Emons J, Gass P, Fasching PA, Egloffstein S, Beckmann MW, Lux MP, Loehberg CR (2020) Analysis of Oncological second opinions in a certified university breast and gynecological cancer center in relation to complementary and alternative medicine. Complement Med Res. https://doi.org/10.1159/000508235
doi: 10.1159/000508235 pubmed: 32544918
Hack CC, Hackl J, Huttner NBM, Langemann H, Schwitulla J, Dietzel-Drentwett S, Fasching PA, Beckmann MW, Theuser AK (2018) Self-reported improvement in side effects and quality of life with integrative medicine in breast cancer patients. Integr Cancer Ther 17(3):941–951. https://doi.org/10.1177/1534735418777883
doi: 10.1177/1534735418777883 pubmed: 29845888 pmcid: 6142097
Huber CM, Barth N, Linde K (2020) How young german general practitioners view and use complementary and alternative medicine: a qualitative study. Complement Med Res. https://doi.org/10.1159/000507073
doi: 10.1159/000507073 pubmed: 32599593
Ostermaier A, Barth N, Schneider A, Linde K (2019) On the edges of medicine—a qualitative study on the function of complementary, alternative, and non-specific therapies in handling therapeutically indeterminate situations. BMC Family Practice 20(1):55. https://doi.org/10.1186/s12875-019-0945-4
doi: 10.1186/s12875-019-0945-4 pubmed: 31014266 pmcid: 6480714
Saxe GA, Madlensky L, Kealey S, Wu DP, Freeman KL, Pierce JP (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the Women’s Healthy Eating and Living Study. Integr Cancer Ther 7(3):122–129. https://doi.org/10.1177/1534735408323081
doi: 10.1177/1534735408323081 pubmed: 18956493 pmcid: 2763208
Harrigan JT (2011) Patient disclosure of the use of complementary and alternative medicine to their obstetrician/gynaecologist. J Obstet Gynaecol 31(1):59–61. https://doi.org/10.3109/01443615.2010.531303
doi: 10.3109/01443615.2010.531303 pubmed: 21280996
Von Gruenigen VE, White LJ, Kirven MS, Showalter AL, Hopkins MP, Jenison EL (2001) A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 11(3):205–209. https://doi.org/10.1046/j.1525-1438.2001.01011.x
doi: 10.1046/j.1525-1438.2001.01011.x
Gray RE, Fitch M, Greenberg M, Voros P, Douglas MS, Labrecque M, Chart P (1997) Physician perspectives on unconventional cancer therapies. J Palliat Care 13(2):14–21
doi: 10.1177/082585979701300204
Gaertner J, Wolf J, Hallek M, Glossmann JP, Voltz R (2011) Standardizing integration of palliative care into comprehensive cancer therapy–a disease specific approach. Support Care Cancer 19(7):1037–1043. https://doi.org/10.1007/s00520-011-1131-y
doi: 10.1007/s00520-011-1131-y pubmed: 21432009
Akpunar D, Bebis H, Yavan T (2015) Use of complementary and alternative medicine in patients with gynecologic cancer: a systematic review. Asian Pacific J Cancer Prevent 16(17):7847–7852. https://doi.org/10.7314/apjcp.2015.16.17.7847
doi: 10.7314/apjcp.2015.16.17.7847
Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG (2002) Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol 84(3):363–367. https://doi.org/10.1006/gyno.2001.6515
doi: 10.1006/gyno.2001.6515 pubmed: 11855870
von Gruenigen VE, Frasure HE, Jenison EL, Hopkins MP, Gil KM (2006) Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol 103(1):120–126. https://doi.org/10.1016/j.ygyno.2006.01.059
doi: 10.1016/j.ygyno.2006.01.059
Muecke R, Paul M, Conrad C, Stoll C, Muenstedt K, Micke O, Prott FJ, Buentzel J, Huebner J (2016) Complementary and alternative medicine in palliative care: a comparison of data from surveys among patients and professionals. Integr Cancer Ther 15(1):10–16. https://doi.org/10.1177/1534735415596423
doi: 10.1177/1534735415596423 pubmed: 26721796
Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, Boyce LM, Tripathy D (2017) Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 67(3):194–232. https://doi.org/10.3322/caac.21397
doi: 10.3322/caac.21397 pubmed: 28436999 pmcid: 5892208
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF): S3-Leitlinie Früherkennung D, Therapie und Nachsorge des, Mammakarzinoms V (2020). https://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/
AGO Kommission Mamma (2020) Komplementäre Therapie. https://www.ago-online.de/fileadmin/ago-online/downloads/_leitlinien/kommission_mamma/2020/PDF_DE/2020D%2023_Komplementaermedizin.pdf . Accessed 14 Oct 2020
Mira TAA, Buen MM, Borges MG, Yela DA, Benetti-Pinto CL (2018) Systematic review and meta-analysis of complementary treatments for women with symptomatic endometriosis. Int J Gynaecol Obstet 143(1):2–9. https://doi.org/10.1002/ijgo.12576
doi: 10.1002/ijgo.12576 pubmed: 29944729

Auteurs

Donata Grimm (D)

Department of Gynecology and Gynecologic Oncology, Hamburg-Eppendorf University Medical Center, Martinistrasse 52, 20246, Hamburg, Germany. donatakatharina.grimm@uksh.de.
Department of Gynecology and Obstetrics, Schleswig-Holstein University Medical Center, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany. donatakatharina.grimm@uksh.de.

Petra Voiss (P)

Department of Internal and Integrative Medicine, Faculty of Medicine, Evangelische Kliniken Essen-Mitte, University of Duisburg-Essen, Am Deimelsberg 34a, 45276, Essen, Germany.

Daniela Paepke (D)

Department of Gynecology and Obstetrics, Klinikum Rechts Der Isar, Technical University of Munich, Ismaninger Strasse 22, Munich, Germany.

Johanna Dietmaier (J)

Department of Gynecology and Gynecologic Oncology, Hamburg-Eppendorf University Medical Center, Martinistrasse 52, 20246, Hamburg, Germany.

Holger Cramer (H)

Department of Internal and Integrative Medicine, Faculty of Medicine, Evangelische Kliniken Essen-Mitte, University of Duisburg-Essen, Am Deimelsberg 34a, 45276, Essen, Germany.

Sherko Kümmel (S)

Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Henricistrasse 92, 45136, MastologyEssen, Germany.

Matthias W Beckmann (MW)

Department of Gynecology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, 91054, Erlangen, Germany.

Linn Woelber (L)

Department of Gynecology and Gynecologic Oncology, Hamburg-Eppendorf University Medical Center, Martinistrasse 52, 20246, Hamburg, Germany.

Barbara Schmalfeldt (B)

Department of Gynecology and Gynecologic Oncology, Hamburg-Eppendorf University Medical Center, Martinistrasse 52, 20246, Hamburg, Germany.

Ulrich Freitag (U)

Dipl. Med. Ulrich Freitag, State Association Chairman of the BVF, Private Practice, Turnerweg 11a, 23970, Wismar, Germany.

Matthias Kalder (M)

Department of Gynecology and Obstetrics, Phillips University of Marburg, Baldingerstrasse, 35033, Marburg, Germany.

Markus Wallwiener (M)

Department of Obstetrics and Gynecology, University of Heidelberg, Im Neuenheimer Feld 672, 69120, Heidelberg, Germany.

Anna-Katharin Theuser (AK)

Institute for Women's Health (IFG) GmbH, Universitätsstrasse 21-23, 91054, Erlangen, Germany.

Carolin C Hack (CC)

Department of Gynecology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitätsstrasse 21-23, 91054, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH